Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J9065
    Short Description Inj cladribine per 1 mg
    Long Description Injection, cladribine, per 1 mg
    Pricing indicator 51
    Coverage code D
    ASC payment group code YY
    BETOS2 code O1D
    Action code N
    Type of service 1
    Effective date 1997-01-01
    Date Added 1995-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    00143987101 J9065 Inj cladribine per 1 mg Cladribine HIKMA PHARMACEUTICALS USA INC. 1 MG 10 1 10 10
    42658001001 J9065 Inj cladribine per 1 mg Cladribine HISUN PHARMACEUTICALS USA, INC. 1 MG 10 1 10 10
    42658001091 J9065 Inj cladribine per 1 mg Cladribine NOVAPLUS/HISUN PHARMACEUTICALS 1 MG 10 1 10 10
    63323014010 J9065 Inj cladribine per 1 mg Cladribine FRESENIUS KABI 1 MG 10 1 10 10
    67457045010 J9065 Inj cladribine per 1 mg Cladribine MYLAN INSTITUTIONAL LLC 1 MG 10 1 10 10
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].

    HCPCS Billing Calculator

    Dosage given to patient (per dose)
    HCPCS Dosage 1 MG
    HCPCS/CPT Billing Units 1
    Total doses ordered
    Billing Units 1

    Drug Details

    • Cladribine is used to treat adults with relapsing forms of multiple sclerosis (MS; a disease in which the nerves do not function properly and people may experience weakness, numbness, loss of muscle coordination, and problems with vision, speech, and bladder control), including relapsing-remitting forms (course of disease where symptoms flare up from time to time) and active secondary progressive forms (course of disease that follows a relapsing-remitting course where symptoms gradually become worse over time). Cladribine is generally used in patients who have already tried another treatment for MS. Cladribine in a class of medications called purine antimetabolites. It works by stopping certain cells of the immune system from causing nerve damage.